Literature DB >> 118074

Mutagenic and DNA-damaging effects of N-alkyl-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines.

M Mochizuki, E Suzuki, T Anjo, Y Wakabayashi, M Okada.   

Abstract

Mutagenic and DNA-damaging effects of a series of N,N-dialkylnitrosamines monosubstituted at the alpha-carbon with an acetoxyl group were tested in Salmonella typhimurium, Escherichia coli, and Bacilus subtilis in the absence of metabolic activation system. The compounds comprised 8 N-alkyl-N-(acetoxymethyl)nitrosamines (alkyl=methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, or tert-butyl) and N-butyl-N-(1-acetoxybutyl)nitrosamine. All the compounds, except one with a tert-butyl group, gave positive results in these mutagenicity and repair tests. Presumed release of alkyl cations from the corresponding alpha-acetoxy derivatives by hydrolysis and heterolysis caused mutagenic and DNA-damaging effects in the bacteria. Structure-activity correlation of the compounds was noted in these tests and discussed in regard to the mutagenicity with metabolic activation and carcinogenicity of N,N-dialkylnitrosamines. The results support the hypothesis that alpha-carbon hydroxylation is one probable mechanism involved in the metabolic activation of N,N-dialkylnitrosamines.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 118074

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  3 in total

1.  Interference of acetoxyalkyl-nitrosamines with limb bud differentiation in organ culture.

Authors:  R Stahlmann; U Bluth; M Wiessler; D Neubert
Journal:  Arch Toxicol       Date:  1983-10       Impact factor: 5.153

2.  Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.

Authors:  M Mochizuki; M Osabe; T Anjo; E Suzuki; M Okada
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  Carcinogenicity of N-alkyl-N-(acetoxymethyl)nitrosamines after subcutaneous injections in F-344 rats.

Authors:  A Maekawa; T Ogiu; H Onodera; K Furuta; C Matsuoka; M Mochizuki; T Anjo; M Okada; S Odashima
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.